New kids on the signaling block
Signal relay in eukaryotes enables proper response to chemical or physical signals received by the cell. We now understand how many of the canonical components of signaling pathways exert their functions, including the mode of activation of many kinases and the relationships among receptors, scaffolds and downstream effectors. This understanding has been key to the development of therapeutics targeting signaling components. Yet, from receptors to enzymes such as kinases, phosphatases, ubiquitin ligases and deubiquitinases, the signaling machinery still holds many mysteries.
In this session, we will focus on atypical signaling mechanisms, from the discovery of new catalysis within the kinome superfamily and noncanonical ubiquitination to the role of metals such as copper in signaling. We also discuss the emergence of pseudoenzymes: These allosteric signaling scaffolds are defined by their structural and sequence homology to canonical enzymes such as kinases and phosphatases, but they lack catalytic activity and remain relatively unexplored biologically and as potential drug targets.
We also will discuss how improvements in phosphoproteomics, genetic screens, and affinity and proximity proteomics permit us to globally assess specific aspects of signal transduction and shine new lights on poorly characterized enzymes, scaffolds and substrates.
Keywords: signal transduction, phosphorylation, ubiquitination, post-translational modification, pseudoenzymes, mass spectrometry, CRISPR screens, structural biology, interaction mapping
Who should attend: everyone who likes taking the road less traveled and those interested in good detective stories
Theme song: “Halo” by Beyoncé
This session is powered by ligands and receptors.
Talks
- CRISPR sensors for signaling — Stéphane Angers, University of Toronto
- Tracing copper utilization by kinase signal transduction pathways: Implications for cancer cell processes — Donita Brady, University of Pennsylvania
- How do signaling pseudoenzymes work? — Patrick Eyers, University of Liverpool
- Proximity-dependent sensors for signaling — Anne-Claude Gingras, Mount Sinai Hospital
- Proteome-scale amino-acid resolution footprinting of protein-binding sites in the intrinsically disordered regions — Ylva Ivarsson, Uppsala University
- Structural basis for signaling by the HER3 pseudokinase — Natalia Jura, University of California, San Francisco
- Defining pseudoenzymes in glycosylation pathways — Natarajan Kannan, University of Georgia
- Cell signaling by protein tyrosine phosphatases — Hayley Sharpe, Babraham Institute, Cambridge
- Expanding the kinome — Vinnie Tagliabracci, University of Texas Southwestern Medical Center
- Pseudoenzyme classification — Janet Thornton, European Molecular Biology Laboratory
- A high-dimensional map of phosphorylation-dependent signaling in budding yeast — Judit Villén, University of Washington
- Noncanonical ubiquitination — Satpal Virdee, University of Dundee
Learn more
Check out all ten thematic symposia planned for the 2022 ASBMB annual meeting:
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Avoiding common figure errors in manuscript submissions
The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.
Ragweed compound thwarts aggressive bladder and breast cancers
Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.
Lipid-lowering therapies could help treat IBD
Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.
Key regulator of cholesterol protects against Alzheimer’s disease
A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.
From humble beginnings to unlocking lysosomal secrets
Monther Abu–Remaileh will receive the ASBMB’s 2026 Walter A. Shaw Young Investigator Award in Lipid Research at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.
Chemistry meets biology to thwart parasites
Margaret Phillips will receive the Alice and C. C. Wang Award in Molecular Parasitology at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.